SEC 13F Intelligence

Bardin Hill Management Partners LP / AMED

Bardin Hill Management Partners LP’s Amedisys Inc Position

Does Bardin Hill Management Partners LP own Amedisys Inc (AMED)? Not currently — the last reported position was 22.0K shares worth $2M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q2 2025
Shares
22.0K
% of Portfolio
+1.28%
Quarters Held
7
position exited

Position History AMED

Reported value by quarter
Q2 ’23: $2MQ2 ’23Q3 ’23: $8MQ3 ’23Q4 ’23: $9MQ4 ’23Q1 ’24: $9MQ1 ’24Q2 ’24: $11MQ2 ’24Q3 ’24: $12MQ3 ’24Q2 ’25: $2MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202522.0K$2M+1.28%
Q3 2024124.3K$12M+5.59%
Q2 2024120.5K$11M+4.49%
Q1 202499.1K$9M+3.81%
Q4 202394.1K$9M+3.81%
Q3 202380.9K$8M+2.43%
Q2 202317.5K$2M+0.41%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bardin Hill Management Partners LP’s full portfolio or all institutional holders of AMED.